lead plaintiff deadline

Apollo Global Management faces a securities class action lawsuit alleging leadership concealed Epstein communications. Investors with losses exceeding $100,000 must apply for lead plaintiff status by May 1, 2026.

FDA rejects Corcept's lead drug candidate, triggering 50% stock plunge and securities class action lawsuit. Lead plaintiff deadline set for April 21, 2026.

Enphase Energy shareholders must file lead plaintiff applications by April 20, 2026 in a class action alleging disclosure failures regarding inventory management and tax credit impacts.

Rosen Law Firm urges PomDoctor Ltd. investors with $100k+ losses to join securities fraud class action before April 7, 2026 deadline, alleging false statements and stock manipulation scheme.

Securities class action filed against NuScale Power over misrepresented ENTRA1 partnership. $495M payment revealed, expenses surged 3,000%, stock down 70% from highs.

Rosen Law Firm files securities class action against Ultragenyx Pharmaceutical ($RARE) alleging false statements about setrusumab efficacy in clinical trials.

Law firm launches class action against $CWH over alleged misstatements on inventory management and demand forecasts between April 2025 and February 2026.

PayPal faces securities class action lawsuit alleging false 2027 financial guidance and concealed salesforce execution gaps. Lead plaintiff deadline: April 20, 2026.

Law firm Faruqi & Faruqi investigates Camping World Holdings for alleged false statements on inventory management. Stock fell 24.8% and 16.5% in Q3 and Q4 2025.

Class action lawsuit filed against $EOS alleging securities fraud over undisclosed production delays, quality control issues, and inadequate guidance during Nov 2025-Feb 2026 period.

BellRing Brands faces class action lawsuit alleging materially false sales statements driven by temporary customer inventory rebuilding, not genuine demand.

Rosen Law Firm alerts Endeavor Group Holdings investors of March 18, 2026 deadline to join securities class action alleging false merger disclosures.

Plug Power faces securities lawsuit over alleged false statements regarding DOE loan and hydrogen facilities. Lead plaintiff deadline is April 3, 2026.

Trip.com faces securities class action over antitrust risk disclosure failures. Stock fell 19.4% after China announced investigation; lead plaintiff deadline set for May 11, 2026.

Rosen Law Firm seeks lead plaintiffs in securities class action against Corcept Therapeutics, alleging misrepresentation of FDA communications and clinical trial data for relacorilant drug.

Rosen Law Firm files securities class action against REGENXBIO for alleged false statements on product safety and efficacy, with April 14, 2026 lead plaintiff deadline.

Shareholder lawsuits against Nektar Therapeutics ($NKTR) and Eos Energy ($EOSE) allege clinical trial and production capacity disclosure failures, with lead plaintiff deadlines in April-May 2026.

Shareholder lawsuits target $KD and $QURE over alleged disclosure violations, with lead plaintiff applications due April 13, 2026. Affected investors may pursue recovery.

Law firm seeks investors in $METC class action over claims company overstated Wyoming mine development progress, triggering 9.6% stock decline.

Lakeland Industries investors have until April 24, 2026 to join securities class action alleging overstatement of Pacific Helmets and Jolly businesses while concealing shipping delays, production issues, and tariff pressures. Stock fell 39% after guidance withdrawal and CFO termination.